Dr. Malay S. Rao, MD

Dr. Rao practices at Physician Partners of Englewood in Englewood, New Jersey.

Dr. Rao's NPI, 1790040178, was assigned on July 11, 2012. Dr. Rao graduated from Rutgers Robert Wood Johnson Medical School in 2010. Dr. Rao holds New Jersey license 26MA09256400.

Dr. Rao's primary practice is Physician Partners of Englewood, at 375 Engle St, Englewood, NJ 07631 in Bergen County. The practice phone is (201) 963-7000.

Dr. Rao's primary practice is Physician Partners of Englewood in Englewood, New Jersey. Dr. Rao is also affiliated with Englewood Hospital. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Rao to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rao practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Rao's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Rao is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Rao's licenses on file in 3 states: New Jersey, Georgia and Texas.

Dmand AI lists bone cancer radiation, brain tumor radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Rao treats.

CMS data shows 1,827 Medicare services from Dr. Rao across 14 procedure codes in 2024, for 151 Medicare patients. Medicare paid $131,658 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 151 Medicare patients who saw Dr. Rao in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rao's median patient age at 74, with 27% women.

In 2024, Dr. Rao wrote 240 Medicare Part D claims for 57 patients. 94% of them were for generic drugs. CMS names the drug for 131 of them, across 6 drugs with 11 or more claims each, at $32,074 in total drug cost. In 2023, CMS named 57 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Rao for performance year 2024, reported through an alternative payment model (APM). Dr. Rao accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Rao. Dr. Rao's most frequent co-authors are Shabbar F. Danish, MD, Bruce G. Haffty, MD and Atif J. Khan, MD.

CMS Open Payments shows 178 general payments to Dr. Rao from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Novocure Inc. paid the most, $4,776.

Dr. Rao graduated from Rutgers Robert Wood Johnson Medical School in 2010.

Dr. Rao is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.